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Abstract
Thb is a retrospective sti.viy of the HSFAMM database evaluating
differences in clinical, labciator , HI V-ribk factors and demographic
characteristics with respect to pendci and ethnicity. There were no
significant differences comparing gender, and Hawaiians and non-
Ha a ans web espect c o w op rga CD4 couvt <230 cells mm
l-iiSPAMM conta ins infcrrriat1nn on a large number of H/V-infected
Asidns/Pacihc Islanders.
Introduction
The State of Hawaii Department of Health estimates that there are
between 2.300 to 3.21)0 individuals li ing in Hawaii who are
infected with the human immunodeficienc\ virus (HIV), Since
1989. the F1as au Sero-Positi vn and Medical Management
HSPAMMj program has pros idcd a means to monitor DIV infec
non v iihui the slate. The purpose of HSPAMM is to ( I) encourage
those ss ho are DIV inlected or at risk bar HIV infection to consult a
pha sican to prevent disease progression. 2 provtdc oncoing
cinieal asistance to participants. S classiR eroups of ntected
people by specilie criteria so that the\ ini\ larticipiite in elincal
trials and research, and 1i iiiainlain anonymous demoeraphic.
clinical and laborator\ rec irds about participants. The HSPAM M
program prov ides semi-annual sits torall its participants with their
,ivvn primary care ph\ sieians. \n HSP-\MM visit consists of a
patient questionnaire, a health pros ider questionnaire, a general
phvsica I e s ami nation. and collection it laboratory sam pie’.
report the descriptis c epideiniological analv sis of the HPSA\IM
database covering April I -Oh) ti. July 21>4)1 The purpose of the studs
was to define vs liether differences c\ist in elmical. laboratory
1tndians. DIV-risk taciors and demscrapltic characteristtcs wth
respect to vender and ethnicity.
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Methods
An overview of how data are obtained through HSPAMM is
displayed in Figure 1 .The patient questionnaire is self-administered
and consists of 43 qoestions. which include the patient’s demo
graphics, risk factors, medical history, medication use, and signs and
symptoms. Ethnic hr was defined as Caucasian .African American,
Hispanic, American Indian. Asian/Pacific Islanders, and other
ethnicities. Asian/Pacific Islanders were further classified as Chi
nese, Japanese. Filipino. Hawaiian/Part Hawaiian (individuals who
report having any Hess aiian heritage), and other Asians ncr of
Hawaiian descent. The questionnaire given at each HSPAMM visit
is repeated and intended to capture changes within the interim
period. The physician medical historr includes the patient’s clinical
signs. svniptoills. health status. onset of opportunistic infections.
and de\ eloprnenl of HR associated diseases. The general phr steal
examination, included in the physician medical histor\ section,
records the patient’s ital signs and review of all oroan 52 stems The
laboratorr portio of the HSPAMM v’,st includes CD4!C[)N-4-
counts. HR v iral I ad. chemistrr panel eleetroivte and liv er
I unction tests’, complete blood count with white blood count dii er
ential, Papanicolaou testuig vsornen. and hepatitis B and C
serologies All data collected from irticipants are recorded under
an individualited code number, in which only the treatiiiu clinician
knows the name ot the participant so as to insure confidentiality.
This i a retrospceiis e descriptive epidemiolovic s tudv of
lISP 3I\I paricipants Horn April 1989 to July 2ttItL Duriie this
period there were mi n r modifications to the questionnaires and
laboratorr testing, these niodifications were made in response to
he increased awareness of the natural progression of H IV disease.
availability of anti-retros iral itedhations and other mcdieatons
used to treat HI\ co nplcations. and impi’oved laboratory technol—
er
. There were a total f ‘HO ariabies collected from the patient
quest nuarc. phr siciali medical history, and lahorators tests.
TIe data vs crc analr ied using SPSS version 10 (SPSS Inc.,
Chicago. IL and S’L\T.\ version StataCHrp. college Station,
TX Descripthe epidemiolocical analyses were performed on all
variables, Group differences vs thin gender. ethnic. and risk factors
were compared usies’ one-way a.nalvsis of variance ,Sinificant
differences across these groups were indicate.d by the F-test, The
source of inter—group differences was determined by using a two-
sided t—test. An alpha level less than 0.05 was considered significant.
An unadjusted Cax proportional hazards model was used to
compare the rate of developing a CD—t count <200 cells/mm among
men and women who had an enrollment CD4 count 200 cells/mm.
Potential risk factors for developing a CD4 count< 200 eells/mm
was examined by using multivariate proportional hazards models
adjusted for ethnicity, enrollment CD4 count, and history of anti
retroviral therapy. Similarly, a Cox proportional hazards model was
used to compare Hass aiians and non—Hawanans in developing a
CD4 count <200 cells/mm. and adjusted for enrollment CD4 count
and histor of anti—retroviral therap . The risk of developing a C’D4
count of <200 cells/mm s as used since this is an acquired immu—
nodehciencv s ndrome AIDS) defining es em. Other AIDS defin
ing events were not consistentls captured h\ HSPAMM.
Results
From April 1989 to July 2001 there has e been 2.-160 HSPA\Pd
participants resulting in 12.832 visits. Incomplete visits, defined as
having one or more missing questionnaires (patient questionnaire.
phsician medical history, and laboratory panel) in a visit, were
detected in 758 (5.9%) visits, Of all visits, there were 69$ missing
patient questionnaires, 698 missing physician medical histories, and
491 missing laboratory sections, The median follow-up was four 6-
month interval visirt.w ith a mean follow-up of six 6—month interval
isits. ()f all participants. I 9 made a single isit. 12% made 2
isits. 10% made 3 visits, and 59% made 4 or more follow-up visits.
There were no differences between length of participation and
gender. African Americans had a substantially shorter length of
participation compared to other ethnic groups (4.8 visits compared
to 6.3 visits). l,ength of participation increased with increasing
income and among the men having sex with men MSM) population.
The average length of HIV infection prior to enrolling in HSPAMM
was 3.8 years (median of 2.0 years) , Annual enrollment by ethnicity
is displayed in Figure 2.
From the patient qtiestionnaire database. 2221 (90.7%) were
male. 196 (8.0%) were female, and 33 (1.3% ( had no response. The
age of these participants at their initial visit ranged from 18.0 to 71 .1
ears mean age 37.2 ears: median age = 36.2 sears: mode age =
37.t) ears). Among partiL’ipantsoverthe past twc years. participants
os er the age of 51) made up 27.9% of the current database. The
demographic characteristics of the F4SPi\lN1 database is shown m
Table I. The distribution of participants residing on each island is
shoss n in Figure 3.
The length of residence in I law au at brst enrollment ranged trom
<1 year to 6% years (mean = 11.3 years’. median = 5.0 years: mode
less than 1 year), .\t first enrollment, participant who mm ed to
Hawaii within 1 year tended to he younger median age of 37 and
mode age of 24) compared to participants who had resided here for
> 5 years (median age of 40 and mode age of 43). Risk factors for
HIV disease are displa\ed in Table 1. Of all participants reporting
ijection drug use (lDl’ on their initial HSP.-\MM visit, 50.1
(1731 reported sharing needles on a regular basis with an average ot
2.3 individuals median 2.0i. The as erage of FISPANIM visits found
22.3 ut participants report using nitrate inhalants. 49.4 man—
}uana. I 7.8% inhaled cocaine. 9,3% mcthamphetamines. 3.2% 1 \
cocaine, and I ,8u l\ heroin. The tacmlmties where partic pants
received their initial HIV positive test were sexually transmitted
disease STD clinics (39.1%). physician offices 131.1%). other
health clinics / hospitals (24. 1%). blood banks (1 .9% . and no
response (3.8%
At enrollment. 1456 of all participants reported an income less
than $20,( 00 6S. 1 %). The number of men and women according to
stratified incomes at enrollment are displayed in Table 1. For
participants with two or more follow-up visits, reported income on
subsequent visits did not change significantly from that reported at
enrollment (mean change in individual income stratification was
+0.7with a standard deviation of + I. I). At the initial ‘ isit. the
housing situation 55 as as folloss 5: 1 2.3% owned their oss n home.
57.2% remed. I I .% ware in te mporai’v housine. 2.7% ss ei’e home
less. and t).6% were in shelters (I 5.4 did not respondi. Of the 66
homeless individuals. 4(3.0% (26) went on to find housing situations
while the rest continued to he homeless.
The average CD4 count at enrollment was 357 cells/mm for men
imedian 33(3) and 399 cells/mm for women 1 median 350>. Of 2.460
participants. 1.657 participants had an enrollment CD4 count > 200
cells/mm3.Thei’e were no significant difference in the cumulative
proportion of men and women in developing a CD4 count of <200
cells/mm3(Hazard Ratio of0.98, 95% CI [0.69. 1.39]. P=0.9 I). This
finding was unchanged even after adjustment for ethnicity. enroll
ment CD4 count and history of anti-reti’oviral therapy use I Hazard
Ratio of 1.07. 95% CI [0.74, l.55j. P=0.7fo (Figure 4>,
The ethnic distribution according to stratified CD4 counts at
eni’ollment is displayed in Table 2. There were minimal diffei’enccs
in stratified CD4 counts betsveen ethnic groups except between
Hawaiians and non-Hawai ans. Thei’e was a significant diffei’ence
of 40 cells/mm’ in mean CD4 counts hetss een Hawaiians and non—
Hawaiians at enrollment. Hawai ians had a median enrollment CD4
count of $0 cells/mm lower than non—l-{assanans. with largest
difference between Hawaiians and Caucasians of 12% cells/mm3.
However, no difference in proportional hazards was seen between
Hawaiians and non-Hawaiians in developing a CD4 count <200
cells/mm (Hazard Ratio of 1.20,95% Cl 10.86, 1.681, P=0.3f)), even
after adjustment for enrollment CD4 count and history of anti
retroviral therapy 1 Hazard Ratio of 102. 95% Cl [0.72. I
P=0.91).
Discussion
Since 1989. HSPAMM has provided the State of Ha’e. an Depart
ment of Health insight into the demographics and health behavior of
this unique group of Hi V—infected indis iduals. Although not all
HIV-infected individuals living in the state pam’ticipate in HSPo\MM.
this group constitutes the largest HIV database in Hass an. The
database is unique in that it allows us to examine the demographic.
clinical and laboratory status of a large HI V-infected population
living in the State. Although the median follow-up is four 6-month
interval visits, 20% of participants have been followed over 5 years.
Enrollment of pai’ticipants was initiall high at about 300 per year in
early 1990’s and has suihsequentl declined. Recent years have seen
HSPAMM enrol Imnent steady at I If)-] 50 p ear (although folloss -
up and utmlizatiomi have increased steadml\ user time. This trend m..
proportional to the estimated incidence of H IV infection in Hawaii.
Possible etiologies for this decline are lesser HSPAMM enrollment.
HR conversion or HIV—infected individuals moving to the stale.
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Although Hawaii is composed of a wide ethnic diversity. Cauca
sian males are disproportionately infected with HIV compared to
other groups. The 20(X) Census shows that of the 1,21 1 537 people
living in the state, 41 6% are Asian (503,868), 243% are Caucasian
(294,102), 94% are Hawaiian/Pacific islander (113,539), 1 $% are
African Americans (21003). and 21 4% are Mixed Non-Hawaiians
(259,343y The number of Caucasians is disproportionately in
fected when compared to other ethnic groups living in Hawaii. The
large number of Asian! Pacific islanders contained in this database
makes this om of tha 1 ircast datab is of HR infcctcd Asian! P utic
Islanders in the country. Asian! Pacific islanders make up 207% of
the HSPAMM database compared to less than I f of all case surveys
in the national AIDS Surveillance database.3The Asian HSPAMM
participants are similar to national AIDS surveillance demographics
in that the majority of participants are MSM (70% compared to 79%
nationallvy1
A large proportion of younger participants were found to have
recently moved to Hawaii at enrollment. This migration to the State
may he secondary to the better health coverage, the HIV Drug
Assistance Program. and environmental/social atmosphere in Ha-
Figure 3— Distribution of HSPAMM participants living in Hawaii
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Figure 1.— Overview of the HSPAMM visit
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waii compared to many parts of the country. Interestingly, seven
physicians were responsible for seeing over 50% of HSPAMM
visits. These 7 physicians are all known members of an association
called the Community Consortium of AIDS Physicians Hawaii, a
physician group that was formed with the purpose of improving [-liv
health care, research and awareness in the State.
The HSPAMM database consisted of older participants compared
to the national average.5Participants greater than the age of 5( make
up 25.8% of all active participants. Butt AA, et al. report that HIV
infected individuals with an age greater than or equal to 60 years was
associated with shorter survival compared to H IV non—infected
individuals.5The health and resource needs of this population can
also he expected to change as more infected individuals enter their
golden years, and increasing emphasis may need to he directed
towards health issues focusing on cardiovascular disease, HiV
lipodystrophy. osteoporosis, and dyslipidemia.
HSPAMM includes [-[[V-infected individuals with and without a
prior diagnosis of AIDS. The treatment of HiV disease is compa
rable to that seen nationally. There were 233 HSPAMM participants
who transitioned trom monotherapy or no anti”retroviral therapy to
highly active anti-retroviral therapy (transition period occurring
between 1995.1996). Results are similar to the Multicenter AIDS
Cohort Study (MACS), in that the use ofhighly active anti-retroviral
therapy (i-IAART) dramatically increased CD4 counts.
Among men, MSM constituted the majority of HSPAMM partici
p ints t69%) shghtly h%hcl than thu sren n LiJon xll (54%
Women made up 8.0 percentage of the database, much less than seen
nationally (32%). The prevalence of HIV infection in women is
unknown since HIV infection is not a reportable disease. The
etiology of this gender disparity in HSPAMM is not known, hut may
suggest cultural and social barriers faced by infected women. There
were socioeconomic differences between men and women. Women
reported a lower education status (40% having attended college
compared to 64% in men) and lower household income compared to
men. However, the women participants in i-1SPAMM had compa
rable immunologic status to male participants. The women had a
higher enrollment CD4 count, As seen in Figure 4, there was no
significant difference in the cumulative proportion of men and
women in developing a CD4 count of <200 cells!mm, even afler
adjustment for ethnicity, enrollment CD4 count and history of anti
retroviral therapy use.
Hawaiians comprise 10% of the entire database and are the largest
group secondary to Caucasians .A lthough no diftèrence in propor
tional hazards was seen between Hawaiians and non-i-Iawaiians in
developing a CD4 count <200 cells/mm’. the enrollment median and
mean CD4 counts of Hawaiians were lower than that of non—
Hawaiians, especially Caucasians. These differences persist with
respect to visit sequences. The median and mean CD4 counts of
Hawaiians appear parallel to counts seen in non- Hawaiians at each
sequence. This difference was no longer seen after Hawaiians were
stratified to enrollment CD4 counts. This may suggest that although
Hawai ians respond to anti—retroviral therapy similarly to other
ethnic groups. they seek medical attention for their HIV infection
later than the other groups. Cultural, socioeconomics and access to
care issues will need to he addressed in future studies.
Limitations of this retrospective study of the HSPAMM database
are mainly from the construction of the database, The database is one
Table 1 .— Demographic characteristics of HSPAMM participants
Male % Female %
Total 2224 92%
Active Participants 761 89%
Ethnicity
African American
American Indian!
Alathan Native
Asian• 425 19% 76 39%
Pacific Islander
Caucasian 1422 64% 84 44%
Hispanic 146 7% 12 6%
Other 110 5% 13 5%
Asian / Pacific Islanders
Hawaiian!
Part Hawaiian
Filipino
Japanese
Chinese
Other Asian
Risk Factors
Men who have sex with
men (MSMI
Injecting drug use (IDUl 82 4%
MSM!IDU 187 8%
Heterosexual Contact 90 4%
Blood! blood products 6 l<t%(
Other 162 7%
Per Capita Income ($)
<10,000 854 40.2%
10.000- 19.999 458 20.6%
20.000 -29.999 296 13.3%
30.000-39.999 192 8.6%
40.000 49.999 106 4.8%
50.000 + 217 9.8%
Length of Residency
< 1 year 528 23.8% 40 20.4%.
1•-S years 597 26.9% 30 15.3%
6-tO years 294 13.2% 25 12.8%
10+ years 733 33.0% 93 47.4%
Noresponse 69 3.1% 8 4.1%
Table 2.— Ethnic distribution according to stratified CD4 counts at
enrollment
CD4 Count (oeils!mm3’(
Am.erican Indian! 1 3 12 5 8
Alaskan Native
Asian’!’ 60 45 81 114 75 102
Pacific Islander
African American 5 8 17 24 25
Caucasian 81 171 335 301 411
Hispanic 9 16 33 31 41
Other 9 21 36 26 31
Hxw’a%an!
Part Hawaiian
Filipino 11 3. 5 13 1.3 13
Japanese 7 4 13 21 15 18
Chinese 3 2 6 13 5 3
OtherA.sian 16 3 6 21 9 17
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that is anonymous, Therefore, validation of datacollected is difficult
to perform and linkage to vital statistics unfeasible, Participants who
dmp out of HSPAMN4 are also dime ult to locate. Controls were not
intended and therefore results of this database are descriptive and
hypothesis generating. The anonymous nature of the program al
lows for the possible duplication of participants. although proce
dures are in place to prevent duplication.
There are two major sources ofbias which preclude generalization
to the HlV-infected population at large. The first is that the cohort
is self-selected. Participation is voluntary and there are many
potential harriers to patient enrollment: denial, economic and cul
tural factors, geographic isolation, and some physician aversion to
paper work, The second source of bias is that a large portion of the
first yeaf s enrollment included only MSM from a previous cohort
established in 1985 called the Hawaii
Describing representative populations such as HSPAMM helps
prioritize and efficiently use human and fiscal resources for disease
control and prevention purposes. Flexibility in modification and
additions to the questionnaire. and clinical and laborator database
can assist administrators and health providers in asking pertinent
health care questions for the future. In addition, FISPAMM provides
necessary services and information to the large proportion of HIV
infected individuals living in Hawaii.
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POISON CENTER TIPS
• Keep the number of the Hawaii Poison Center on
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Center.
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Until there’s a cure
there’s the
American Diabetes
Association.
Donate to help us save lives.
Mail checks, payable to:
Hawaii Poison Center
1 319 Punahou Street, Honolulu, HI 96826
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